2m 2m 2m 2m 2m 2m 2m
PTC Therapeutics (PTCT)
NASDAQ
$63.48-$0.65 (-1.02%)
Price as of Oct 02, 2026 5:07 PM EDT- $5.4BMarket Cap
- 1.76%1-Year Change
- BiotechnologyIndustry
PTC Therapeutics (PTCT)
$63.48-$0.65 (-1.02%)
PTCT | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $64.13 | ||
Change | -$0.65 (-1.00%) | ||
Open | $64.70 | ||
High | $65.56 | ||
Low | $63.40 | ||
Previous Close | $64.78 | ||
Volume | 1,197,752 | ||
30-Day Average Volume | 1,219,503 | ||
1-Week Change | 2.97% | ||
1-Month Change | -9.11% | ||
1-Year Change | 1.76% | ||
3-Year Change | 186.17% | ||
5-Year Change | 69.97% | ||
Fundamentals | |||
Shares Outstanding | 83.5M | ||
Total Assets | $3.3B | ||
Market Cap | $5.4B | ||
Enterprise Value | $4.9B | ||
Period: QTR TTM FY | |||
Revenue | $238.8M | ||
Net Income | $83.5M | ||
Free Cash Flow | $126.9M | ||
EBIT | $146.0M | ||
EBITDA | $161.9M | ||
Net Working Capital | $1.8B | ||
EPS | $0.92 | ||
Enterprise Value/EBITDA | 30 | ||
Enterprise Value/Revenue | 20 | ||
P/B | -32 | ||
P/E | 70 | ||
PEG | 0 | ||
Price/Free Cash Flow | 42 | ||
Price/Operating Cash Flow | 41 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue